ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,615.35
      0.55%
      US Tech 100
      19,804.00
      0.64%
      Dow Jones
      40,000.90
      0.62%
      Brent Oil
      84.57
      0.00%
      Bitcoin
      60,129.85
      1.51%
      Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Aeterna Zentaris Inc (AEZS)

      7. Aeterna Zentaris Inc (AEZS) News

      AEZS

      Aeterna Zentaris (AEZS)

      		Date:
      Sort by:
       Showing the most relevant articles for your search:NASDAQ:AEZS
      DateTimeSourceHeadlineSymbolCompany
      01/26/20123:30AMZacksZacks #1 Rank Additions for Thursday - Tale of the TapeNASDAQ:AEZSAeterna Zentaris Inc
      01/25/20128:20AMMarketwiredBiotechnology Industry on the Upswing -- Aeterna Zentaris and Elite Pharmaceuticals to BenefitNASDAQ:AEZSAeterna Zentaris Inc
      01/24/20126:02AMEdgar (US Regulatory)Report of Foreign Issuer (6-K)NASDAQ:AEZSAeterna Zentaris Inc
      01/24/20126:02AMEdgar (US Regulatory)Voluntary supplemental material filed pursuant to Section 11(a) of the Securities Act of 1933 by foreign issuers (SUPPL)NASDAQ:AEZSAeterna Zentaris Inc
      01/23/20125:56PMPR Newswire (US)Aeterna Zentaris Announces "At-the-Market" Issuance ProgramNASDAQ:AEZSAeterna Zentaris Inc
      01/05/20128:16AMMarketwiredDendreon and AEternaZentaris Look for Stronger Performance in 2012NASDAQ:AEZSAeterna Zentaris Inc
      01/05/20127:30AMPR Newswire (US)Aeterna Zentaris Announces Collaboration with Ventana Medical Systems, Inc. to Develop Companion Diagnostic in Cancer for AEZ...NASDAQ:AEZSAeterna Zentaris Inc
      01/03/20127:30AMPR Newswire (US)Aeterna Zentaris Partner, Yakult Honsha, Initiates Phase 1/2 Trial with Perifosine in Colorectal Cancer in JapanNASDAQ:AEZSAeterna Zentaris Inc
      12/14/20119:00AMMarketwiredA Change in Tides - Featured Research on Keryx Biopharmaceuticals and AEterna Zentaris Inc. (USA)NASDAQ:AEZSAeterna Zentaris Inc
      12/13/20118:00AMPR Newswire (US)Aeterna Zentaris: Encouraging Clinical Data for Perifosine in Hodgkin Lymphoma Presented at ASH MeetingNASDAQ:AEZSAeterna Zentaris Inc
      12/12/20118:00AMPR Newswire (US)Aeterna Zentaris: Encouraging Preclinical Data for Perifosine in Hodgkin Lymphoma Presented at ASH MeetingNASDAQ:AEZSAeterna Zentaris Inc
      12/09/20117:30AMPR Newswire (US)Aeterna Zentaris Presents Positive Preclinical Data in Breast Cancer on AEZS-131, a Highly Selective Erk 1/2 Inhibitor, at Sa...NASDAQ:AEZSAeterna Zentaris Inc
      12/05/20118:00AMPR Newswire (US)Aeterna Zentaris: Presentations on Perifosine Scheduled at Upcoming ASH Meeting in San Diego, CaliforniaNASDAQ:AEZSAeterna Zentaris Inc
      11/28/20118:16AMMarketwiredCheap Valuations in Viral Genetics and AEterna Zentaris Embraced by InvestorsNASDAQ:AEZSAeterna Zentaris Inc
      11/28/20117:30AMPR Newswire (US)Aeterna Zentaris: FDA Grants IND to Investigator at Baylor College of Medicine for Phase 2A Trial with AEZS-130 in Cancer Cac...NASDAQ:AEZSAeterna Zentaris Inc
      11/23/20117:30AMPR Newswire (US)Aeterna Zentaris and Hikma Pharmaceuticals Sign a Commercialization and Licensing Agreement for Lead Oncology Compound, Perif...NASDAQ:AEZSAeterna Zentaris Inc
      11/22/20117:30AMPR Newswire (US)Aeterna Zentaris to Present at Upcoming Piper Jaffray and Oppenheimer Healthcare Conferences in New YorkNASDAQ:AEZSAeterna Zentaris Inc
      11/16/20117:30AMPR Newswire (US)Aeterna Zentaris Presents Encouraging Preclinical Data for Disorazol Z (AEZS-137) at AACR-NCI-EORTC ConferenceNASDAQ:AEZSAeterna Zentaris Inc
      11/10/20119:59AMEdgar (US Regulatory)Report of Foreign Issuer (6-K)NASDAQ:AEZSAeterna Zentaris Inc
      11/10/20119:52AMEdgar (US Regulatory)Report of Foreign Issuer (6-K)NASDAQ:AEZSAeterna Zentaris Inc
      11/10/20117:00AMPR Newswire (US)Aeterna Zentaris Reports Third Quarter 2011 Financial and Operating ResultsNASDAQ:AEZSAeterna Zentaris Inc
      11/04/20118:16AMMarketwiredHighly Anticipated Drugs From BioSante and AEterna Zentaris May Not Be as Lucrative as ExpectedNASDAQ:AEZSAeterna Zentaris Inc
      11/03/20117:30AMPR Newswire (US)Aeterna Zentaris to Report Third Quarter 2011 Financial and Operating Results on November 10, 2011NASDAQ:AEZSAeterna Zentaris Inc
      11/01/20117:30AMPR Newswire (US)Aeterna Zentaris to Present at Upcoming Major Cancer ConferencesNASDAQ:AEZSAeterna Zentaris Inc
      10/25/20117:30AMPR Newswire (US)Aeterna Zentaris: FDA Grants IND to Investigator at University of Miami School of Medicine for Phase 2 Trial with AEZS-108 in...NASDAQ:AEZSAeterna Zentaris Inc
      10/20/20118:16AMMarketwiredLate Stage Drugs From BioSante and AEterna Zentaris Could Reawaken Interest in Biotech SectorNASDAQ:AEZSAeterna Zentaris Inc
      10/13/201110:04AMPR Newswire (US)Phase 1/2 Clinical Trial Results of Perifosine Plus Bortezomib and Dexamethasone in Patients with Relapsed/Refractory Multipl...NASDAQ:AEZSAeterna Zentaris Inc
      10/13/20119:33AMPR Newswire (US)Phase 1 / 2 Clinical Trial Results of KRX-0401 (Perifosine) Plus Bortezomib and Dexamethasone in Patients with Relapsed/Refra...NASDAQ:AEZSAeterna Zentaris Inc
      10/05/20118:35AMPR Newswire (US)Aeterna Zentaris: Journal of Clinical Oncology Publishes Phase 2 Clinical Trial Results of Perifosine Plus Capecitabine in Pa...NASDAQ:AEZSAeterna Zentaris Inc
      10/05/20118:30AMPR Newswire (US)Journal of Clinical Oncology Publishes Phase 2 Clinical Trial Results of KRX-0401 (Perifosine) Plus Capecitabine in Patients ...NASDAQ:AEZSAeterna Zentaris Inc
       Showing the most relevant articles for your search:NASDAQ:AEZS